Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will ...
Weight-loss drugs are everywhere, but how many Aussies are actually taking them?
A new class of weight-loss drugs touted as a revolutionary breakthrough in obesity management have received global attention, ...
Why Novo Nordisk A/S (NVO) Is the Best ADR Stock to Invest in?
We recently published a list of 12 Best ADR Stocks To Invest In According to Analysts. In this article, we are going to take ...
Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger
The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...
Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...